Join our community of smart investors

Impellam's global play proves well timed

The recruitment consultancy delivered on its international expansion
Impellam's global play proves well timed

Organisations generally tend to avoid handing out employment contracts when the economy is in a state of uncertainty. The Brexit vote, coupled with candidate shortages in education and NHS pay rate caps, meant that the odds were firmly against Impellam (IPEL) in 2016.

IC TIP: Buy at 764p

Fortunately, acquisitions made the previous year helped the UK's second-largest staffing business by revenue to find recruitment opportunities elsewhere. With Michigan-based Bartech and healthcare specialist Global Group on board, Impellam ended the year registering a surge in top-line growth and a 21 per cent rise in adjusted cash profit to £70.1m.

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in